ILAE-North America
The current ILAE-North America region was constituted in 2006, comprising English speaking North American Chapters of Canada, the United States of America, and the English speaking Caribbean (represented by Jamaica). The Mexican chapter, although geographically in North America, is a member of the Latin American Regional Commission.
Our goals and aims are aligned with the ILAE’s emphasis on current and emerging knowledge on epilepsy prevention, diagnosis, treatment, research, and optimal comprehensive epilepsy care.
NEW! Global Health in Epilepsy Project Database
The Global Health Task Force has just launched an initiative to identify and connect international projects aimed at reducing the global epilepsy treatment gap, and it is now accepting ongoing, completed, and upcoming projects.
The goals are to increase collaboration, amplify impact, reduce redundancy, engage possible funders, and identify service opportunities.
Latest News
About ILAE
News about COVID-19 from ILAE
Find information about the COVID-19 virus and epilepsy, read FAQs, and take surveys in many languages. Also find out about the new ILAE research award, and get an email address to share information on our resources page. ILAE information on COVID-19 and Epilepsy Do you have an unusual case…
21 July, 2020
About ILAE
Call for comments on new wearable seizure detection devices clinical guideline
A joint EEG Task Force from the ILAE and the International Federation of Clinical Neurophysiology (IFCN) has developed a proposed clinical practice guideline for automated seizure detection using wearable devices.
14 July, 2020
About ILAE
Welcome Julie Hall!
ILAE is pleased to announce that Dr Julie Hall has been appointed as the first Executive Director of the ILAE. Julie has enormous experience in various positions as director and chief of staff of large international organizations, most recently as Chief of Staff of the International Federation of Red Cross Red Crescent Societies.
11 July, 2020
About ILAE
Epilepsia Impact Factor increased to 6.040!
Epilepsia's Impact Factor has increased to 6.040, from 5.562. The journal is now ranked 20/204 in the Clinical Neurology JCR category, up from 25 last year. Read about Epilepsia® and how to subscribe
9 July, 2020
World News
In memoriam: Professor Chrysostomos P. Panayiotopoulos
We regret to announce that Professor Chrysostomos P. Panayiotopoulos (“Tomis”), one of the fathers of modern epileptology who discovered the Panayiotopoulos Syndrome, has died at age 82.
2 July, 2020
Subscribe to the ILAE Newsletter
To subscribe, please click on the button below.
Please send me information about ILAE activities and other
information of interest to the epilepsy community